 1. Diagnosis of MF either primary or post essential thrombocythemiapolycythemia vera requiring therapy, including those previously treated and relapsed or refractory, or if newly diagnosed, with intermediate-1 or -2 or high risk according to International Prognostic Scoring System IPSS. 